Literature DB >> 20362495

Predictors of severe manifestations in a cohort of adult dengue patients.

Laurent Thomas1, Yannick Brouste, Fatiha Najioullah, Patrick Hochedez, Yves Hatchuel, Victor Moravie, Stéphane Kaidomar, François Besnier, Sylvie Abel, Jacques Rosine, Philippe Quenel, Raymond Césaire, André Cabié.   

Abstract

BACKGROUND: Key symptoms observed during the febrile phase of dengue may identify patients who are likely to progress to severe disease.
OBJECTIVES: To test this hypothesis, we examined the relationships between symptoms reported by patients at presentation and the development of severe outcomes. STUDY
DESIGN: Retrospective analysis of data recorded prospectively in 560 adult dengue patients admitted to an emergency department. A logistic regression analysis was used to quantify the association between symptoms reported at presentation and outcome.
RESULTS: Plasma leakage was observed in 95 patients (17%), severe thrombocytopenia (platelet counts <20 x 10(9)/L) in 93 patients (16.6%) and acute hepatitis in 42 patients (7.5%). Severe thrombocytopenia developed in 57% of patients with plasma leakage and 40.5% of patients with hepatitis. Patients who developed a plasma leakage syndrome were older, mainly male, and reported more often an abdominal pain and a cough. Diarrhea and taking paracetamol >60 mg/kg/day before admission were associated with the development of acute hepatitis. Seven patients died. The mortality rate was 6/95 (6.3%) in patients who developed plasma leakage, 3/42 (7.1%) in patients who developed hepatitis, 5/93 (5.4%) in patients with severe thrombocytopenia, and 3/12 (25%) in the patients who demonstrated together all these severe manifestations.
CONCLUSION: Plasma leakage, severe thrombocytopenia and acute hepatitis identified subgroups of adult dengue patients with increased mortality rates. Key symptoms reported by the patients at presentation such as abdominal pain, cough or diarrhea were significantly associated with the development of severe manifestations and should be considered as warning signs. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20362495     DOI: 10.1016/j.jcv.2010.03.008

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  17 in total

1.  Decreased peripheral dendritic cell numbers in dengue virus infection.

Authors:  Marcelo De Carvalho Bittencourt; Jenny Martial; André Cabié; Laurent Thomas; Raymond Césaire
Journal:  J Clin Immunol       Date:  2011-10-04       Impact factor: 8.317

2.  Is zinc concentration in toxic phase plasma related to dengue severity and level of transaminases?

Authors:  Kamolwish Laoprasopwattana; Chonthicha Tangcheewawatthanakul; Wanutsanun Tunyapanit; Rassamee Sangthong
Journal:  PLoS Negl Trop Dis       Date:  2013-06-20

3.  Evaluation of the WHO revised criteria for classification of clinical disease severity in acute adult dengue infection.

Authors:  S D Jayaratne; Vajini Atukorale; Laksiri Gomes; Thashi Chang; Tharindu Wijesinghe; Sachie Fernando; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  BMC Res Notes       Date:  2012-11-20

4.  Early clinical features of dengue virus infection in nicaraguan children: a longitudinal analysis.

Authors:  Hope H Biswas; Oscar Ortega; Aubree Gordon; Katherine Standish; Angel Balmaseda; Guillermina Kuan; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2012-03-06

5.  Comparison of real-time SYBR green dengue assay with real-time taqman RT-PCR dengue assay and the conventional nested PCR for diagnosis of primary and secondary dengue infection.

Authors:  Damodar Paudel; Richard Jarman; Kriengsak Limkittikul; Chonticha Klungthong; Supat Chamnanchanunt; Ananda Nisalak; Robert Gibbons; Watcharee Chokejindachai
Journal:  N Am J Med Sci       Date:  2011-10

Review 6.  Is diabetes a risk factor for a severe clinical presentation of dengue?--review and meta-analysis.

Authors:  Nan Shwe Nwe Htun; Peter Odermatt; Ikenna C Eze; Noémie Boillat-Blanco; Valérie D'Acremont; Nicole Probst-Hensch
Journal:  PLoS Negl Trop Dis       Date:  2015-04-24

7.  Dengue NS1 antigen as a marker of severe clinical disease.

Authors:  Shiran Ajith Paranavitane; Laksiri Gomes; Achala Kamaladasa; Thiruni N Adikari; Nilanka Wickramasinghe; Chandima Jeewandara; Narangoda Liyanage Ajantha Shyamali; Graham Stuart Ogg; Gathsaurie Neelika Malavige
Journal:  BMC Infect Dis       Date:  2014-10-31       Impact factor: 3.090

8.  Utilities and limitations of the World Health Organization 2009 warning signs for adult dengue severity.

Authors:  Tun-Linn Thein; Victor C Gan; David C Lye; Chee-Fu Yung; Yee-Sin Leo
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

9.  Predictive tools for severe dengue conforming to World Health Organization 2009 criteria.

Authors:  Luis R Carrasco; Yee Sin Leo; Alex R Cook; Vernon J Lee; Tun L Thein; Chi Jong Go; David C Lye
Journal:  PLoS Negl Trop Dis       Date:  2014-07-10

10.  Dynamic Measurement of Hemodynamic Parameters and Cardiac Preload in Adults with Dengue: A Prospective Observational Study.

Authors:  Vipa Thanachartwet; Anan Wattanathum; Duangjai Sahassananda; Petch Wacharasint; Supat Chamnanchanunt; Ei Khine Kyaw; Akanitt Jittmittraphap; Mali Naksomphun; Manoon Surabotsophon; Varunee Desakorn
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.